Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.

Chen H, Li X, Yue R, Ren X, Zhang X, Ni A.

Diabetes Res Clin Pract. 2013 May;100(2):272-6. doi: 10.1016/j.diabres.2013.03.007. Epub 2013 Mar 21.

PMID:
23522918
3.

Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.

Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.

Life Sci. 2005 Jul 22;77(10):1130-9.

PMID:
15978265
4.
5.

Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus.

Sosa M, Dominguez M, Navarro MC, Segarra MC, Hernández D, de Pablos P, Betancor P.

J Diabetes Complications. 1996 Jul-Aug;10(4):201-5.

PMID:
8835919
6.

The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.

Celik E, Guzel S, Abali R, Guzelant AY, Celik Guzel E, Kuçukyalcin V.

Minerva Med. 2013 Oct;104(5):497-504.

PMID:
24101107
7.

Increasing serum osteocalcin after glycemic control in diabetic men.

Sayinalp S, Gedik O, Koray Z.

Calcif Tissue Int. 1995 Dec;57(6):422-5.

PMID:
8581873
8.

Bone turnover in hyperthyroidism before and after thyrostatic management.

Isaia GC, Roggia C, Gola D, Stefano MD, Gallone G, Aimo G, Ardissone P, Mussetta M.

J Endocrinol Invest. 2000 Dec;23(11):727-31.

PMID:
11194705
9.

The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.

Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, Inaba M, Nishizawa Y.

Osteoporos Int. 2005 Feb;16(2):172-9. Epub 2004 May 26.

PMID:
15164161
10.

Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.

Olmos JM, Pérez-Castrillón JL, García MT, Garrido JC, Amado JA, González-Macías J.

Bone Miner. 1994 Jul;26(1):1-8.

PMID:
7950501
11.

[Effects of occupational lead exposure on bone mineral density and bone metabolism in workers].

Sun Y, Jin TY, Sun DH, Zhu GY, Lei LJ, Zhang HY, Shen GZ.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2007 May;25(5):257-62. Chinese.

PMID:
17621417
12.
13.

Age- and gender-related differences in bone mineral status and biochemical markers of bone metabolism in Northern Chinese men and women.

Yan L, Prentice A, Zhou B, Zhang H, Wang X, Stirling DM, Laidlaw A, Han Y, Laskey A.

Bone. 2002 Feb;30(2):412-5.

PMID:
11856650
14.

Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism.

Movahed A, Larijani B, Nabipour I, Kalantarhormozi M, Asadipooya K, Vahdat K, Akbarzadeh S, Farrokhnia M, Assadi M, Amirinejad R, Bargahi A, Sanjdideh Z.

J Bone Miner Metab. 2012 Nov;30(6):683-91. doi: 10.1007/s00774-012-0367-z. Epub 2012 Jul 3.

PMID:
22752126
16.

Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.

Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM.

J Bone Miner Res. 1995 Aug;10(8):1177-84.

PMID:
8585420
17.

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

Guo CY, Weetman AP, Eastell R.

Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7.

PMID:
9156039
18.

Alterations in serum levels of 1 alpha,25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy.

Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y.

Diabetes Res Clin Pract. 1997 Oct;38(1):53-9.

PMID:
9347246
19.

Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.

Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T.

J Natl Med Assoc. 2006 Oct;98(10):1598-604.

Supplemental Content

Support Center